| |
|
|
|
AMAG Pharmaceuticals Inc.  
|
|
13.75 0 (0%) |
11-13 16:00 |
|
Open: |
13.75 |
Pre close: |
13.75 |
Target:
|
16.07
|
|
High: |
13.76 |
Low: |
13.75 |
Resistance:
|
13.76
16.07
|
|
Volume: |
1,534,573 |
Market Cap: |
477M |
Support:
|
13.49
13.32
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
13.74
 |
MACD |
MACD(12,26):
|
0.35  |
|
MA(20): |
13.70 |
Signal(12,26,9): |
0.46 |
|
MA(100): |
10.79 |
Stochastic Oscillator |
%K(14,3):
|
90.79 |
|
MA(250): |
9.60 |
%D(3): |
86.67 |
|
Average Volume(K) |
3-Month: |
176327
|
52-Week |
High:
|
13.80 |
|
10-Days: |
147570 |
Low: |
4.41 |
|
RSI |
RSI(14):
|
72.24 |
Change(%): |
42.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-6.770 |
Return on Equity (ttm) |
-62.9 |
Shares Out. (M) |
34.73 |
|
EPS Est. Current Year |
-1.390 |
Return on Assets (ttm) |
-3.1 |
Shares Float (M) |
23.40 |
|
EPS Est. Next Year |
-1.720 |
PEG Ratio |
0.00 |
% Held by Insiders |
2.29 |
|
EPS Est. Next Quarter |
0.270 |
Qtrly Rev. Growth |
11.1 |
% Held by Institutions |
102.74 |
|
Forward EPS |
-13.710 |
Gross Profit (p.s.) |
6.316 |
Shares Short (K) |
6290 |
|
Book Value (p.s.) |
7.420 |
EBITDA (p.s.) |
-1.036 |
P/E |
-2.03 |
|
Sales Per Share |
8.642 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.85 |
|
Profit Margin |
-77.18 |
Operating Cash Flow
(M) |
-26.73 |
P/S |
1.59 |
|
Operating Margin |
-13.88 |
Levered Free Cash Flow
(M) |
14.82 |
P/CF |
-17.87 |
|
|
|
|
|
|
